FDA Committee Recommends COMIRNATY® Booster for Emergency Use in People 65+
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the FDA’s Vaccines and Related Biological Products Advisory Committee
Read more
Infectious Diseases
AstraZeneca and EU Reach Settlement on COVID-19 Vaccine Delivery
AstraZeneca and the European Commission and have reached a settlement on the delivery of pending COVID-19 vaccine doses by the
Read more
UK Approves Regeneron/Roche COVID-19 Monoclonal Antibody Cocktail
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a Conditional Marketing Authorization (CMA) for Regeneron’s antibody cocktail to treat
Read more
Pfizer-BioNTech COVID-19 Vaccine First to be Fully Approved by the FDA
The U.S. Food and Drug Administration announced on Monday it has approved the Pfizer-BioNTech COVID-19 Vaccine. The vaccine which will
Read more
FDA Grants EUA for Two Next-Gen COVID-19 Assays from Thermo Fisher
The global leader in serving science, Thermo Fisher Scientific has announced that the U.S. Food and Drug Administration (FDA) has
Read more
COVID-19 antibodies enable tissue-based detection of viral infection
HistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read more
Novel Lipases of Microbial Origin for Superior Performance
Novel lipases of microbial origin selected and engineered for best performance. A EUCODIS Bioscience Case Study EUCODIS Bioscience offers a
Read more
Vaxzevria Highly Effective against Beta/Gamma and Delta Variants
Real-world data has shown the Vaxzevria vaccine (formerly AZD1222), co-developed by AstraZeneca, the University of Oxford and its spin-out company,
Read more
FDA Approves Merck’s VAXNEUVANCE™ Pneumococcal 15-valent Conjugate Vaccine
Merck, also known as MSD, revealed that the U.S. Food and Drug Administration (FDA) has authorised VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate
Read more
University of Oxford Starts Phase I Clinical Trial of Novel HIV Vaccine
The University of Oxford has commenced a Phase I clinical trial of a novel HIV vaccine candidate with vaccinations underway
Read more